PB-22-d9
- CAS No.
- 2484977-00-4
- Chemical Name:
- PB-22-d9
- Synonyms
- PB-22-d9;1-pentyl-2,2',3,3',4,4',5,5,5-d9-8-quinolinylester-1H-indole-3-carboxylicacid
- CBNumber:
- CB24666200
- Molecular Formula:
- C23H13D9N2O2
- Molecular Weight:
- 367.488436002
- MDL Number:
- MOL File:
- 2484977-00-4.mol
- MSDS File:
- SDS
SAFETY
Risk and Safety Statements
| Symbol(GHS) | ![]() GHS07 |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Signal word | Warning | |||||||||
| NFPA 704 |
|
PB-22-d9 price More Price(5)
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| Cayman Chemical | 14298 | PB-22-d9 ≥99%deuteratedforms(d1- |
2484977-00-4 | 500μg | $87 | 2026-04-30 | Buy |
| Cayman Chemical | 14298 | PB-22-d9 ≥99%deuteratedforms(d1- |
2484977-00-4 | 1mg | $165 | 2026-04-30 | Buy |
| Cayman Chemical | 22871 | PB-22-d9 (exempt preparation) ≥99%deuteratedforms(d1- |
2484977-00-4 | 1mg | $193 | 2026-04-30 | Buy |
| Cayman Chemical | 14298 | PB-22-d9 ≥99%deuteratedforms(d1- |
2484977-00-4 | 5mg | $255 | 2026-04-30 | Buy |
| Cayman Chemical | 22871 | PB-22-d9 (exempt preparation) ≥99% deuterated forms (d1- |
2484977-00-4 | 1 mg | $175 | 2024-03-01 | Buy |
PB-22-d9 Chemical Properties, Uses, Production
Description
PB-22-d9 (exempt preparation) (Item No. 22871) is intended for use as an internal standard for the quantification of PB-22 (Item No. ISO00122) by GC- or LC-MS. PB-22 is categorized as a synthetic cannabinoid.1 It mimics the effects of Δ9-THC (Item Nos. 12068 | ISO60157). PB-22 is regulated as a Schedule I compound in the United States. PB-22-d9 (exempt preparation) (Item No. 22871) is provided as a DEA exempt preparation. This product is intended for research and forensic applications.WARNING This product is not for human or veterinary use.
References
[1] SAMUEL D. BANISTER. Effects of Bioisosteric Fluorine in Synthetic Cannabinoid Designer Drugs JWH-018, AM-2201, UR-144, XLR-11, PB-22, 5F-PB-22, APICA, and STS-135[J]. ACS Chemical Neuroscience, 2015, 6 8: 1445-1458. DOI: 10.1021/acschemneuro.5b00107





